Selection of the treatment strategies of myelodysplastic syndromes based on clone category / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 759-762, 2011.
Article
Dans Chinois
| WPRIM
| ID: wpr-472395
ABSTRACT
Myelodysplastic syndromes(MDS) are heterogeneous clonal stem cell disorders.There are about 40 %-60 % MDS patients with abnormal karyotype.To analyze the clone category is not only useful for diagnosis and evaluating prognosis,but also helpful for the selection of optimal therapy strategies to improve the treatment efficacy.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Journal of Leukemia & Lymphoma
Année:
2011
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS